Vaxcyte, Inc. PCVX
65.68 USD +4.87 (+8.01%)
At closeNov 5, 2026, 4:00 AM EST
65.01 -0.67 -1.02%
Pre-market · Nov 5, 4:00 AM ET
60.04 Day range 65.71
39.87 52-week range 90.75
- YTD
- +42.35%
- 1 year
- +58.84%
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -923.67M | -569.55M | -468.04M | -232.26M | -103.67M | |
| -766.63M | -463.93M | -402.27M | -223.49M | -100.08M | |
| -5.63 | -3.80 | -4.14 | -3.44 | -1.93 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 173.96M | 387.88M | 397.45M | 834.66M | 68.98M | |
| 3.00B | 3.51B | 1.41B | 1.01B | 324.34M | |
| 317.21M | 205.50M | 167.45M | 52.56M | 40.32M | |
| 117.58M | 71.11M | 29.22M | 17.94M | 16.78M | |
| 2.69B | 3.31B | 1.24B | 953.61M | 284.02M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -655.58M | -452.63M | -296.79M | -170.60M | -121.39M | |
| 437.35M | -2.01B | -773.31M | 74.58M | -212.31M | |
| 2.01M | 2.45B | 639.81M | 861.55M | 17.80M | |
| -56.97M | -119.16M | -67.88M | -5.84M | -6.53M | |
| -213.77M | -9.36M | -436.97M | 765.67M | -316.34M |